Immunome, Inc. · NASDAQ:IMNM
Lechleider Robert sold 55,000 Immunome, Inc. shares (Form 4)
Traded Jul 2, 2026 · Filed Jul 7, 2026
On Jul 2, 2026, Lechleider Robert (Chief Medical Officer) sold 55,000 Immunome, Inc. shares at an average US$22.62 for US$1.24M under a trading plan, leaving 15,805 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 55,000 shares
- Price
- US$22.62 average (US$21.95 to US$23.44)
- Value
- US$1.24M
- Holding after
- 15,805 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | Option exercise | 55,000 | US$8.73 | 70,805 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 22,714 | US$21.95 | 48,091 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 16,214 | US$22.76 | 31,877 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 16,072 | US$23.44 | 15,805 | Direct |
Source
Related
- Immunome, Inc.
- Lechleider Robert
- Immunome, Inc. shareholders
- Form 4 · Lechleider Robert · Jul 27, 2026
- Form 4 · Lechleider Robert · Jun 29, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026